1227608-07-2 Usage
General Description
3,4-Dimethylthiophene-2-sulfonyl chloride is a chemical compound with the molecular formula C8H9ClOS2. It is a derivative of thiophene, a heterocyclic compound containing a sulfur atom in its five-membered ring. 3,4-Dimethylthiophene-2-sulfonyl chloride is a sulfonyl chloride, meaning it contains a sulfonyl group (-SO2Cl) which is a versatile functional group used in organic synthesis for the introduction of a sulfonyl moiety. 3,4-Dimethylthiophene-2-sulfonyl chloride has potential applications in pharmaceutical and agrochemical industries as a building block for the synthesis of various biologically active compounds. It also has the potential for use in material science and as a reagent for chemical research and analysis.
Check Digit Verification of cas no
The CAS Registry Mumber 1227608-07-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,6,0 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1227608-07:
(9*1)+(8*2)+(7*2)+(6*7)+(5*6)+(4*0)+(3*8)+(2*0)+(1*7)=142
142 % 10 = 2
So 1227608-07-2 is a valid CAS Registry Number.
InChI:InChI=1S/C6H7ClO2S2/c1-4-3-10-6(5(4)2)11(7,8)9/h3H,1-2H3
1227608-07-2Relevant articles and documents
2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE
-
Page/Page column 216, (2021/06/26)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA compounds) that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aaRS) (e.g., bacterial leucyl-tRNA synthetase, LeuRS). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase; to treat disorders that are ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetase; to treat bacterial infections; etc.
